Title : A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.

Pub. Date : 2005 Apr

PMID : 16124953

1 Functional Relationships(s)
Compound Name
Protein Name
1 A nonsignificant trend toward higher rates of major bleeding was seen at 7 days for enoxaparin-treated patients, in both the overall safety population and the population of patients who did not receive antithrombin treatment before randomization, but there was no difference in blood transfusions. Enoxaparin serpin family C member 1 Homo sapiens